Ablation vs Amiodarone for Treatment of AFib in Patients With CHF and an ICD
Status:
Completed
Trial end date:
2015-12-01
Target enrollment:
Participant gender:
Summary
1. To determine if catheter-based atrial fibrillation (AF) ablation is superior to
Amiodarone treatment for symptomatic persistent/permanent AF in ICD/CRTD patients with
an impaired left ventricular function.
2. Hypothesis: AF ablation is better than Amiodarone for subjects with symptomatic
persistent or permanent AF and impaired LV function in terms of recurrence of AF,
quality of life, 6-minute walk distance, EF and total number of hospitalizations.
Phase:
Phase 4
Details
Lead Sponsor:
Texas Cardiac Arrhythmia Research Foundation
Collaborators:
Casa Sollievo della Sofferenza IRCCS Catholic University, Italy Southlake Regional Health Centre Stanford University Sutter Health The University of Texas Medical Branch, Galveston University of Foggia University of Kansas